Tibet Weixinkang Medicine Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QQ3
CNY
11.23
-0.02 (-0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
273.05
287.54
292.35
303.10
357.34
312.15
314.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
273.05
287.54
292.35
303.10
357.34
312.15
314.32
Raw Material Cost
103.96
113.40
125.97
153.52
168.68
156.61
153.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.08
0.03
0.05
0.03
0.05
0.06
0.08
Selling and Distribution Expenses
88.13
79.70
70.16
90.02
83.01
76.98
78.94
Other Expenses
2.59
2.39
1.85
3.36
2.09
2.02
2.18
Total Expenditure (Excl Depreciation)
218.12
216.98
214.65
277.17
272.59
253.84
254.61
Operating Profit (PBDIT) excl Other Income
54.900000000000006
70.6
77.69999999999999
25.9
84.80000000000001
58.3
59.699999999999996
Other Income
-1.67
30.52
14.95
5.10
5.91
11.48
47.57
Operating Profit (PBDIT)
50.22
112.39
105.51
20.21
104.11
83.32
120.74
Interest
0.08
0.03
0.05
0.03
0.05
0.06
0.08
Exceptional Items
10.53
13.24
1.29
0.08
-1.48
4.99
-0.62
Gross Profit (PBDT)
169.09
174.14
166.38
149.58
188.67
155.54
160.52
Depreciation
0.00
12.41
12.41
13.81
13.81
13.45
13.45
Profit Before Tax
60.67
113.19
94.34
6.45
88.78
74.79
106.58
Tax
24.28
14.94
9.79
3.55
8.97
6.25
11.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.39
98.25
84.54
2.90
79.81
68.55
94.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.39
98.25
84.54
2.90
79.81
68.55
94.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.39
98.25
84.54
2.90
79.81
68.55
94.91
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,526.46
1,490.11
1,469.90
1,385.44
1,482.27
1,402.87
1,435.29
Earnings per share (EPS)
0.08
0.23
0.2
0.01
0.18
0.16
0.22
Diluted Earnings per share
0.08
0.23
0.2
0.01
0.18
0.16
0.22
Operating Profit Margin (Excl OI)
19.0%
24.16%
26.73%
0.43%
23.62%
18.71%
19.0%
Gross Profit Margin
22.22%
43.68%
36.51%
6.68%
28.71%
28.27%
38.19%
PAT Margin
13.33%
34.17%
28.92%
0.96%
22.33%
21.96%
30.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -5.01% vs -1.64% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -62.93% vs 16.21% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -36.63% vs -9.60% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Tibet Weixinkang Medicine Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
273.05
0
273.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
273.05
0
273.05
Raw Material Cost
103.96
0
103.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.08
0
0.08
Selling and Distribution Expenses
88.13
0
88.13
Other Expenses
2.59
0.00
2.59
Total Expenditure (Excl Depreciation)
218.12
0
218.12
Operating Profit (PBDIT) excl Other Income
54.93
0.00
54.93
Other Income
-1.67
0
-1.67
Operating Profit (PBDIT)
50.22
0
50.22
Interest
0.08
0
0.08
Exceptional Items
10.53
0
10.53
Gross Profit (PBDT)
169.09
0
169.09
Depreciation
0.00
0
0.00
Profit Before Tax
60.67
0
60.67
Tax
24.28
0
24.28
Provisions and contingencies
0
0
0.00
Profit After Tax
36.39
0
36.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
36.39
0
36.39
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.39
0
36.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,526.46
0
1,526.46
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
19.00%
0%
0.00
19.00%
Gross Profit Margin
22.22%
0%
0.00
22.22%
PAT Margin
13.33%
0%
0.00
13.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 27.31 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.01% vs -1.64% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -23.57% vs 15.89% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.64 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -62.93% vs 16.21% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -54.39% vs 4.72% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.19 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -36.63% vs -9.60% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -47.15% vs 107.61% in Sep 2024

Quarterly - Interest
Interest 0.01 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.00%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024